News & Events 2010
December 2010, Incepta pioneered the launch of the first Insulin analogue, Insulin Glargine (rDNA), brand name Vibrenta, in Bangladesh.
In 2010, Incepta was accepted by the global headquarters of UN agencies at Copenhagen, Denmark and became enlisted as global supplier to UNICEF, UNESCO, and UNDP.
05 August 2010
National Drug Authority (NDA) of the Republic of Uganda issued GMP certificates to Incepta Pharmaceuticals Ltd. for sterile, non sterile and cephalosporin products.